Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.H. Kantarjian, AB Deisseroth, M Keating et al.|Journal of Clinical Oncology|1992Cited by 65
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersStephen O’Brien, MJ Keating, Razelle Kurzrock et al.|Blood|1994Cited by 63